HIV-associated obstructive lung diseases: insights and implications for the clinician.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementHIV and COPD: a conspiracy of risk factorsFactors associated with abnormal spirometry among HIV-infected individualsFrailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation.A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung DiseaseCOPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated.A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV.Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection.Chronic Morbidity Among Older Children and Adolescents at Diagnosis of HIV InfectionCopenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark.Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.HIV infection model of chronic obstructive pulmonary disease in mice.Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol.HIV and ageing: improving quantity and quality of life.Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral LoadCoexpression Analysis of Transcriptome on AIDS and Other Human Disease Pathways by Canonical Correlation Analysis.Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.HIV-related chronic lung disease in adolescents: are we prepared for the future?HIV-related chronic obstructive pulmonary disease. Are lung CD4 T cells bothered?HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.Influenza immunisation: knowledge and actions taken by UK HIV-positive adults.Validation of lung density indices by cardiac CT for quantification of lung emphysema
P2860
Q26799659-EAD618A3-88B7-4684-A5C8-02B1D8E141ECQ28072795-2B66EB1B-1DF3-4D12-BB38-854083CFED38Q28388780-8A1B5E82-C4C4-4BD1-B858-599FDFF79EF8Q30248351-312DE738-EC3D-4382-B8C8-D75937F821C7Q34550471-B0D52D7D-46B5-46E1-ACB1-4CAE114D6E70Q34987059-415E852B-F3A7-41D9-82ED-CE36EC7BC741Q35941456-862E9E0C-CC32-4594-94C0-4E3002D21004Q36102809-AB983D67-90D7-40FC-9D4C-8EAFDB92D3B0Q36240320-6A2DCE7B-8A56-4A12-8AF3-8260D311A285Q36259851-DDDA4FA7-CE94-4A05-A5BE-BD7FBF0BE1ABQ37080373-D8ED2BC9-40CB-4751-B4DA-02DE3FF6494FQ37342422-7D2C5302-A985-45EA-91A7-C32BBD7A8751Q37442717-ADF2DA02-C623-4E8C-8F97-3B15A55E4F19Q37613840-9E3D8831-B872-4443-B2A1-20CB673D0C97Q38768300-5F2B9AEA-93CB-448F-BF80-F97CBAF3F827Q38868531-61797FDF-21BA-4777-A9BE-8A857D03CB11Q38883328-6D407417-6313-4124-BFA9-778DAA1ED3B8Q39037971-AD99D912-36FB-4496-B1D9-92E1A56DB0E8Q39242862-7E7463D8-ECC3-487B-B6A0-3A0D43F13E6AQ40128097-35C78494-3BF4-4458-AD70-19E8A4BA5421Q40292019-1BEE6982-205D-4879-9654-188975838004Q40504067-E0549B31-E5DA-4BB5-8326-B13B2D7D7E71Q41928756-716CD7AC-14B7-40C5-90AA-62FFD2B9DB47Q44018086-BDFAED63-6EB7-4F39-82A0-C056289799DCQ47260481-142C1B69-88E4-48D0-A0BA-478400536C00Q47984024-020489C8-DB40-40A6-9BCC-55019FA0653FQ51598214-29AAC981-18A5-4DC2-A871-514871916E5BQ57815909-B6F933F0-2D26-49BF-AEE0-1279A1A6E3FD
P2860
HIV-associated obstructive lung diseases: insights and implications for the clinician.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@ast
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@en
type
label
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@ast
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@en
prefLabel
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@ast
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@en
P2860
P1476
HIV-associated obstructive lung diseases: insights and implications for the clinician.
@en
P2093
Gregory D Kirk
M Bradley Drummond
P2860
P304
P356
10.1016/S2213-2600(14)70017-7
P577
2014-05-13T00:00:00Z